Status:
ENROLLING_BY_INVITATION
A Prospective Cohort Study for Patients With Adrenal Diseases
Lead Sponsor:
Seoul National University Hospital
Conditions:
Adrenal Adenoma
Cushing Syndrome
Eligibility:
All Genders
19+ years
Brief Summary
The purpose of this study is to investigate the pathologic features, complications, and prognostic factors of functioning adrenal adenoma and suggest follow-up algorithms for adrenal incidentaloma.
Detailed Description
The investigators will recruit 150 patients annually for 10 years (adrenal incidentaloma 100 patients, pheochromocytoma 15 patients, primary aldosteronism 25 patients, adrenal cushing syndrome 10 pati...
Eligibility Criteria
Inclusion
- Adults, male or female aged 19 years or older
- newly diagnosed with adrenal disease such as adrenal incidentaloma, pheochromocytoma, primary aldosteronism, adrenal cushing syndrome, adrenocortical carcinoma
Exclusion
- previous or current history of adrenal diseases
- using oral or intravenous steroids
- history of major depressive disorder
- history of chronic alcoholics
- history of any cancer with suspicious adrenal metastasis
- those with acute illness (ex- patients with acute coronary syndrome within 4 weeks, acute febrile disease)
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03474237
Start Date
October 1 2018
End Date
December 31 2027
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080